CN110129243B - Soy yogurt suitable strains, inoculants and their applications - Google Patents
Soy yogurt suitable strains, inoculants and their applications Download PDFInfo
- Publication number
- CN110129243B CN110129243B CN201910534345.8A CN201910534345A CN110129243B CN 110129243 B CN110129243 B CN 110129243B CN 201910534345 A CN201910534345 A CN 201910534345A CN 110129243 B CN110129243 B CN 110129243B
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- microbial inoculum
- scb0469
- lactococcus lactis
- cfu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 115
- 239000002054 inoculum Substances 0.000 title claims description 14
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 172
- 244000068988 Glycine max Species 0.000 claims abstract description 141
- 239000002068 microbial inoculum Substances 0.000 claims abstract description 131
- 244000057717 Streptococcus lactis Species 0.000 claims abstract description 85
- 235000014897 Streptococcus lactis Nutrition 0.000 claims abstract description 85
- 235000013336 milk Nutrition 0.000 claims abstract description 81
- 239000008267 milk Substances 0.000 claims abstract description 81
- 210000004080 milk Anatomy 0.000 claims abstract description 81
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 67
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 67
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 52
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 52
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 52
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 46
- 238000004321 preservation Methods 0.000 claims abstract description 14
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 64
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 39
- 238000000855 fermentation Methods 0.000 claims description 38
- 230000004151 fermentation Effects 0.000 claims description 38
- 230000001580 bacterial effect Effects 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 244000199866 Lactobacillus casei Species 0.000 claims description 24
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 24
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 24
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 24
- 229940017800 lactobacillus casei Drugs 0.000 claims description 24
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 24
- 235000013322 soy milk Nutrition 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000009629 microbiological culture Methods 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 235000020186 condensed milk Nutrition 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 230000003044 adaptive effect Effects 0.000 abstract description 45
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract description 36
- 235000008696 isoflavones Nutrition 0.000 abstract description 36
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 20
- 239000000796 flavoring agent Substances 0.000 abstract description 17
- 235000019634 flavors Nutrition 0.000 abstract description 17
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract description 16
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract description 16
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract description 16
- 244000005700 microbiome Species 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 description 32
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 21
- 102000036639 antigens Human genes 0.000 description 18
- 108091007433 antigens Proteins 0.000 description 18
- 235000003687 soy isoflavones Nutrition 0.000 description 17
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 12
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 10
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 10
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 9
- 230000004071 biological effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229960004793 sucrose Drugs 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 235000007240 daidzein Nutrition 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000000890 antigenic effect Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 6
- 239000003651 drinking water Substances 0.000 description 6
- 235000020188 drinking water Nutrition 0.000 description 6
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 5
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 5
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 5
- 238000009928 pasteurization Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108010044091 Globulins Proteins 0.000 description 4
- 102000006395 Globulins Human genes 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000006539 genistein Nutrition 0.000 description 4
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 4
- 229940045109 genistein Drugs 0.000 description 4
- 108010083391 glycinin Proteins 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 description 3
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 description 3
- 235000015141 kefir Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033546 Pallor Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000433 anti-nutritional effect Effects 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 235000010855 food raising agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000020122 reconstituted milk Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000318836 Pleurotus nebrodensis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010565 inoculated fermentation Methods 0.000 description 1
- -1 isoflavone glycosides Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/06—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/157—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of microorganisms, in particular to a bean yogurt adaptive strain, a microbial inoculum and application thereof. The soy yogurt adaptive strain is selected from any one or more of the following strains: 1) lactobacillus rhamnosus SCB0119, the preservation number is: CGMCC 17618; 2) lactococcus lactis SCB0469 with the deposit number: CGMCC 17619; 3) lactobacillus helveticus SCB0641 with a collection number of: CGMCC 17620; all three strains are preserved in China center for culture Collection of microorganisms for 24 days at 4 months in 2019. The microbial inoculum is obtained by reasonable compatibility, and the mixed soybean milk is fermented to obtain the soybean yogurt with good curd effect and good flavor, and the soybean isoflavone can be biologically converted to improve the content of free soybean isoflavone aglycone.
Description
Technical Field
The invention relates to the technical field of microorganisms, in particular to a bean yogurt adaptive strain, a microbial inoculum and application thereof.
Background
The traditional yoghourt is an animal fermented food which is obtained by taking fresh milk or reconstituted milk as a raw material and carrying out processing by process technologies such as blending, homogenizing, sterilizing, cooling, inoculating a leavening agent and the like and microbial fermentation. The bean yoghourt is a plant (or animal) fermented food which is obtained by taking fresh soybean milk or recovered soybean milk as a raw material, adding or not adding fresh milk or recovered milk, processing by the process technologies of blending, homogenizing, sterilizing, cooling, inoculating a leavening agent and the like, and fermenting by microorganisms.
After the fresh milk or the reconstituted milk is added in the preparation of the bean yoghourt, compared with the traditional yoghourt, the soybean yoghourt combines the advantages of the milk and the soybean and simultaneously makes up the defects of the milk and the soybean, and has more comprehensive and rich protein types, amino acid compositions, fat types and vitamin types and more balanced nutrition. The addition of the milk makes up the defects of poor curding capability, strong beany flavor and poor taste and flavor when the soybean milk is simply fermented, and the existence of the soybean milk makes up the defect that the traditional yoghurt lacks dietary fibers, and particularly brings the natural active substances of soybean isoflavone to the soybean yoghurt.
The soybean isoflavone is a natural active substance existing in soybeans, has various active effects of protecting cardiovascular system, preventing atherosclerosis, preventing osteoporosis, relieving female climacteric symptoms, resisting tumor and oxidation, protecting nerves, regulating immunity, protecting liver and the like, and has excellent application prospect and market prospect. At present, some organizations in Japan propose that the upper limit of the intake of soybean isoflavone in daily diet is 70-75 mg/d, and the upper limit of the intake of soybean isoflavone added outside diet is 30 mg/d. In European Union, the recommended intake of soybean isoflavone is 40-100 mg/d according to EC 1924/2006.
Under natural conditions, the content of soybean isoflavone in soybeans is about 0.1-0.5%, 12 isomers are generally considered, including 9 bound glycosides mainly comprising daidzin, genistin and the like and 3 free-type aglycones comprising daidzein, genistein and glycitein, wherein the bound glycoside accounts for 97-98%, and the free-type aglycone only accounts for 2-3%. Change and Nair (1995) found that soybean isoflavone glycoside is difficult to be absorbed and utilized by human body, compared with soybean isoflavone aglycone which is easier to be absorbed and utilized by human body. Xu et al (1995) and Wei et al (1996) have suggested that soybean isoflavone aglycones have higher biological activity than soybean isoflavone glycosides, and that soybean isoflavones have multiple active effects when present in the aglycone form. The soybean isoflavone glycoside can be hydrolyzed into soybean isoflavone aglycone by beta-glucosidase secreted by part of intestinal microorganisms, but the composition of intestinal flora varies from person to person, so that the conditions of synthesizing and secreting the beta-glucosidase and converting the soybean isoflavone in a human body are different, and the amount of the soybean isoflavone aglycone which is finally converted is limited. In conclusion, the biological conversion of the soybean isoflavone can effectively improve the biological activity and the bioavailability of the soybean isoflavone in the organism, and has very important significance.
According to data records of soybean germplasm resource databases of the institute of crop science of the academy of agricultural sciences of China and soybean germplasm resource databases of the department of agriculture of the United states, the content of protein in soybeans is 30.8-57.9%, the soybean protein is high-quality protein like milk protein, and the soybean protein mainly comprises albumin (accounting for about 10%) and globulin (accounting for about 90%). According to immunological analysis, globulin contains 40% of glycinin and 30% of beta-conglycinin, which are main antigen proteins in soybean and are easy to cause adverse reactions such as allergy and the like. However, the two antigen proteins have stronger heat stability, and the heat treatment at the temperature of 100 ℃ has little influence on the antigen activity. Therefore, researchers have turned to methods for removing antigenic proteins, and have improved the nutritional properties of soy products by reducing their antigenic activity through fermentation with microorganisms such as lactic acid bacteria.
In view of the above, the present invention is particularly proposed.
Disclosure of Invention
The invention aims to provide a soy yogurt adaptive strain, which can biologically convert soy isoflavone, thereby improving the content of aglycon soy isoflavone components and improving the biological activity and bioavailability in a body.
The second purpose of the invention is to provide a bean yoghourt adaptive microbial inoculum, which can be used for bean yoghourt adaptive fermentation after the bacterial strain is scientifically matched, reduce the content of antigen protein in the bean yoghourt, and release and improve the nutrition of the bean yoghourt.
The third purpose of the invention is to provide the application of the bean yoghourt adaptive microbial inoculum in the preparation of the bean yoghourt, and the bean yoghourt prepared by using the bean yoghourt adaptive microbial inoculum can obtain good curd effect and improve the flavor of the bean yoghourt.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
a soy yogurt-compatible strain selected from any one or more of the following strains:
a) lactococcus lactis SCB0469, Lactococcus lactis, deposited in the China general microbiological culture Collection center, with the deposit numbers: CGMCC 17619; the preservation time is as follows: 24 months 4 in 2019;
b) lactobacillus rhamnosus SCB0119, Lactobacillus rhamnosus, preserve in China center for culture of microorganisms, the preserving number is: CGMCC 17618; the preservation time is as follows: 24 months 4 in 2019;
c) lactobacillus helveticus SCB0641, Lactobacillus helveticus, is preserved in China center for culture of microorganisms with the preservation number: CGMCC 17620; the preservation time is as follows: 24/4/2019.
The morphological description characteristics of each strain are respectively as follows: a colony morphology chart obtained after lactobacillus rhamnosus SCB0119 strain is inoculated on an MRS solid culture medium and cultured for 72 hours at the temperature of 37 ℃. The colony diameter is 1.48-2.75mm, and the colony is round, white, glossy, opaque, moist, low around the middle bulge, and smooth and complete edge.
A colony morphology obtained after the lactococcus lactis strain SCB0469 was inoculated on an MRS solid medium and cultured at a temperature of 30 ℃ for 72 hours. The colony diameter is 1.42-2.90mm, and the colony is round, white, glossy, slightly transparent, moist, slightly convex in the middle, low in periphery, smooth and complete in edge.
A colony morphology obtained after lactobacillus helveticus SCB0641 strain was inoculated on MRS solid medium and cultured at 37 ℃ for 72 hours. The colony diameter is 1.35-2.20mm, and the colony is round, white, glossy, slightly transparent, slightly moist, low in middle protrusion, smooth and complete in edge.
The 16SrDNA sequence of Lactobacillus rhamnosus (Lactobacillus rhamnosus) SCB0119 has 1380 nucleotides, and the sequence is shown as SEQ ID NO: 1 is shown.
The 16SrDNA sequence of Lactococcus lactis (Lactococcus lactis) SCB0469 has 1419 nucleotides, and the sequence is shown as SEQ ID NO: 2, respectively.
The 16SrDNA sequence of Lactobacillus helveticus (Lactobacillus helveticus) SCB0641 has 1409 nucleotides, and the sequence is shown as SEQ ID NO: 3, respectively.
The three strains are all preserved in the China general microbiological culture Collection center, and the preservation addresses are as follows: xilu No. 1, Beijing, Chaoyang, Beijing, and institute for microbiology, China academy of sciences.
The lactococcus lactis SCB0469 has the main effects of serving as a soy yogurt flavor strain and improving the flavor of soy yogurt, the lactobacillus rhamnosus SCB0119 has the main effects of removing antigen protein in soy milk and converting soy isoflavone, and the lactobacillus helveticus SCB0641 has the main effects of converting soy isoflavone and improving the content of aglycone soy isoflavone in the soy yogurt.
The bean yoghurt adaptive strain is a safe edible strain which has any one or more of the following effects by fermenting pure bean milk (or mixed bean milk): (1) can produce pleasant flavor, (2) can effectively remove anti-nutritional factors, and (3) can biologically convert the soybean isoflavone to improve the content of the aglycone soybean isoflavone so as to improve the biological activity and the bioavailability of the aglycone soybean isoflavone.
According to the strain provided by the invention, the strain number of the lactobacillus rhamnosus is SCB0119, the strain number of the lactococcus lactis is SCB0469, and the strain number of the lactobacillus helveticus is SCB 0641.
The lactobacillus rhamnosus SCB0119 provided by the invention is separated from Sichuan pickle and is obtained by dilution and pouring plate separation.
The lactococcus lactis SCB0469 provided by the invention is separated from Russian kefir and is obtained by dilution and pouring on a plate.
The Lactobacillus helveticus SCB0641 provided by the invention is separated from Tibetan spiritual mushroom by a dilution and pouring plate method.
The invention claims the bean yoghourt adaptive strain with the preservation number and the mutant strain which has mutation in a moderate range and still has strong bean yoghourt adaptive capability.
In the practical application process, the bean yoghourt adaptive strain can be expanded and cultured to form a composition, namely a bean yoghourt adaptive starter (or a bean yoghourt adaptive microbial inoculum) which is in the form of a microbial inoculum so as to expand the application range of the bean yoghourt adaptive bacterial strain in consideration of the possible transportation and other reasons.
The bean yoghourt adaptive starter is a bean yoghourt direct vat set type freeze-dried starter prepared by 2 or more lactic acid bacteria strains which are prepared by scientifically matching bean yoghourt adaptive strains, can generate pleasant flavor, can biologically convert soybean isoflavone to improve the content of aglycon type soybean isoflavone so as to improve the biological activity and the bioavailability and/or can effectively remove anti-nutritional factors and improve the nutritional efficacy of the bean yoghourt.
The invention also provides a microbial inoculum containing the strain.
In some embodiments of the present invention, the microbial inoculum may further include any one or more of streptococcus thermophilus, lactobacillus plantarum, lactobacillus casei and lactobacillus paracasei.
In some embodiments of the present invention, the microbial inoculum preferably comprises at least lactococcus lactis SCB 0469.
The strain can be the existing strain, and can improve the fermentation effect and the like by being matched with the strain obtained by separation.
Specifically, the streptococcus thermophilus, the lactobacillus plantarum, the lactobacillus casei and the lactobacillus paracasei can be used as the bacteria for fermenting the common yoghourt.
In some specific embodiments of the invention, in the microbial inoculum, the ratio of the lactobacillus rhamnosus SCB0119 to the lactobacillus lactis SCB0469 to the lactobacillus helveticus SCB0641 is (0-1.22 × 10) in terms of the number of viable bacteria10)﹕ (1.0×106~3.60×1010)﹕(0~8.55×1010). Preferably, the ratio of the three bacteria in the microbial inoculum is (1X 10) in terms of viable count7~8×109)﹕(1×107~8×109)﹕(1×107~8×109) (ii) a More preferably, the ratio of the three bacteria in the microbial inoculum is (6.5X 10) in terms of viable count7~6×109)﹕(1.2×107~5.5×109)﹕(1.8×107~ 4×109)。
In some specific embodiments of the invention, in the microbial inoculum, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus lactis SCB0469, the lactobacillus helveticus SCB0641 and the streptococcus thermophilus is (0-1.22 × 10) in terms of the number of viable bacteria10) ﹕(1.0×106~3.60×1010)﹕(0~8.55×1010)﹕(0~4.54×109). Preferably, the ratio of the four bacteria in the microbial inoculum is (1X 10) in terms of viable count7~8×109)﹕(1×107~8×109)﹕(1×107~8×109) ﹕(1×106~4×109) (ii) a More preferably, the ratio of the four bacteria in the microbial inoculum is (6.5X 10) in terms of viable count7~6×109) ﹕(1.2×107~5.5×109)﹕(1.8×107~4×109)﹕(3×106~3×109)。
The specific implementation mode of the invention provides several scientific compatibility modes, which are as follows:
the microbial inoculum comprises Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469 and Lactobacillus paracasei. The ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469 and Lactobacillus paracasei is preferably (6.5X 10) in terms of viable count7~3.0×109)﹕(1.5×108~5.0×109) ﹕(1.5×108~3.0×109)﹕(4.0×108~7.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus. Further preferably, the microbial inoculum also comprises lactobacillus plantarum and/or lactobacillus casei.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactococcus lactis SCB0469, the lactobacillus paracasei and the streptococcus thermophilus in the microbial inoculum is (6.5 multiplied by 10)7~2.5×109)﹕(4.0×108~4.0×109)﹕(1.5×108~2.5×109)﹕ (4.5×108~7.0×109)﹕(2.0×107~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469, Lactobacillus paracasei, and Streptococcus thermophilus is (9.0 × 10) based on the number of viable bacteria7~5.0×108)﹕(4.0×108~8.0×108)﹕ (1.5×108~5.0×108)﹕(1.0×109~7.0×109)﹕(2.0×107~6.0×107)。
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactococcus lactis SCB0469, the lactobacillus paracasei, the streptococcus thermophilus, the lactobacillus plantarum and the lactobacillus casei in the microbial inoculum is (6.5 multiplied by 10)7~2.5×109)﹕(4.0×108~4.0×109)﹕ (1.5×108~2.5×109)﹕(4.5×108~7.0×109)﹕(2.0×107~3.0×109)﹕(3.0×108~ 5.0×109)﹕(5.5×108~5.5×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, lactococcus lactis SCB0469, Lactobacillus paracasei, Streptococcus thermophilus, Lactobacillus plantarum, and Lactobacillus casei is (3.5 × 10) based on the number of viable bacteria8~2.5×109)﹕(4.0×108~ 4.0×109)﹕(1.5×108~2.5×109)﹕(4.5×108~5.5×109)﹕(1.0×108~3.0×109) ﹕(3.0×108~5.0×109)﹕(5.5×108~5.5×109)。
The microbial inoculum comprises lactococcus lactis SCB0469 and Lactobacillus helveticus SCB 0641. The ratio of lactococcus lactis SCB0469 to Lactobacillus helveticus SCB0641 is preferably (1.2X 10) in terms of the number of viable bacteria7~2.5×109)﹕(1.8×107~ 4.0×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus and/or lactobacillus paracasei.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactococcus lactis SCB0469, the Lactobacillus helveticus SCB0641 and the Streptococcus thermophilus is (1 multiplied by 10) in terms of the number of the viable bacteria in the microbial inoculum7~2.5×109)﹕(1.5×107~ 4.0×109)﹕(3×106~3×109). Preferably, in the present inventionIn some embodiments, the ratio of the viable bacteria count of the lactococcus lactis SCB0469, the Lactobacillus helveticus SCB0641 and the Streptococcus thermophilus is (1.2 × 10)7~1.5×107) ﹕(1.8×107~2.5×107)﹕(3×106~8×106). Or the ratio of Lactobacillus helveticus SCB0641, Lactobacillus paracasei and lactococcus lactis SCB0469 in terms of viable count in the microbial inoculum is (3.0 × 10)8~5.0×109): (4.0×108~5.5×109)﹕(1.5×108~2.5×109). More preferably, the ratio of the lactobacillus helveticus SCB0641, the lactobacillus paracasei SCB0469 and the streptococcus thermophilus in the microbial inoculum is (4.0 × 10) in terms of the number of the viable bacteria8~4.0×109):(4.5×108~5.5×109)﹕(1.5×108~2.5×109)﹕(1.0×108~ 3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus helveticus SCB0641, Lactobacillus paracasei, lactococcus lactis SCB0469, Streptococcus thermophilus (4.0X 10) is calculated by the number of viable bacteria8~6.0×108): (4.5×108~9.5×108)﹕(6×108~1.0×109)﹕(5.0×108~1.5×109)。
The microbial inoculum comprises Lactobacillus rhamnosus SCB0119 and Lactobacillus lactis SCB 0469. In the microbial inoculum, the ratio of Lactobacillus rhamnosus SCB0119 to lactococcus lactis SCB0469 is preferably (6.5 multiplied by 10) in terms of the number of viable bacteria7~6×109) ﹕(1.5×108~3.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus rhamnosus SCB0119, the lactococcus lactis SCB0469 and the streptococcus thermophilus is (6.5 multiplied by 10) in terms of the number of the viable bacteria in the microbial inoculum7~6×109)﹕(1.5×108~ 3.5×109)﹕(2×107~3×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus rhamnosus SCB0119, lactococcus lactis SCB0469 and Streptococcus thermophilus, based on the number of viable bacteria, is: (1×109~6×109)﹕ (1×109~3.5×109)﹕(8×107~8×108)。
The microbial inoculum comprises lactobacillus casei and lactococcus lactis SCB 0469. In the microbial inoculum, the ratio of lactobacillus casei to lactococcus lactis SCB0469 is preferably (4 × 10) in terms of viable count8~8×109)﹕(1×108~2.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus casei, the lactococcus lactis SCB0469 and the streptococcus thermophilus in the microbial inoculum is (5.5 multiplied by 10) in terms of viable count8~5.5×109)﹕(1.5×108~2.5×109) ﹕(4×107~3×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus casei, lactococcus lactis SCB0469 and Streptococcus thermophilus is (1.0X 10) based on the number of viable bacteria9~5.5×109)﹕(9×108~2.5×109) ﹕(4×107~8×107)。
The microbial inoculum comprises lactobacillus paracasei and lactococcus lactis SCB 0469. In the microbial inoculum, the ratio of lactobacillus paracasei to lactococcus lactis SCB0469 is (3 multiplied by 10) in terms of the number of viable bacteria8~7.0×109)﹕(1.5×108~2.5×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus paracasei, the lactococcus lactis SCB0469 and the streptococcus thermophilus in the microbial inoculum is (4.5 multiplied by 10)8~7.0×109)﹕(1.5×108~ 2.5×109)﹕(2.0×107~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus paracasei, lactococcus lactis SCB0469 and Streptococcus thermophilus is (1X 10) based on the number of viable bacteria9~7.0×109) ﹕(2×108~6×108)﹕(1×108~8×108)。
The microbial inoculum comprises lactobacillus plantarum and lactococcus lactis SCB 0469. The ratio of Lactobacillus plantarum to lactococcus lactis SCB0469 in terms of viable count in the microbial inoculum is preferably (3 × 10)8~8×109)﹕(1.5×108~8.0×109). More preferably, the microbial inoculum further comprises streptococcus thermophilus.
When the microbial inoculum is adopted, in some specific embodiments, the ratio of the lactobacillus plantarum to the lactococcus lactis SCB0469 to the streptococcus thermophilus is (3 x 10) in terms of the number of viable bacteria in the microbial inoculum8~5×109)﹕(1.5×108~5.5×109)﹕ (1.0×108~3.0×109). Preferably, in some embodiments of the present invention, the ratio of Lactobacillus plantarum, lactococcus lactis SCB0469, and Streptococcus thermophilus is (3X 10) in terms of viable count8~6×108)﹕(1×109~5.5×109) ﹕(1.0×108~3.0×109)。
In different embodiments, the bacterial agent can be 0, 1 × 10 and 1 × 10 in terms of the number of active bacteria of lactobacillus rhamnosus SCB01197cfu/L、2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、 7×107cfu/L、8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、 4×108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、 1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、6×109cfu/L、 7×109cfu/L、8×109cfu/L、9×109cfu/L、1×1010cfu/L、1.22×1010cfu/L, etc.;
lactococcus lactis SCB0469 may be: 1.0X 106cfu/L、2×106cfu/L、3×106cfu/L、 4×106cfu/L、5×106cfu/L、6×106cfu/L、7×106cfu/L、8×106cfu/L、9×106cfu/L、 1×107cfu/L、2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、 7×107cfu/L、8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、 4×108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、 1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、6×109cfu/L、 7×109cfu/L、8×109cfu/L、9×109cfu/L、1×1010cfu/L、2×1010cfu/L、3×1010cfu/L、 3.6×1010cfu/L, etc.;
lactobacillus helveticus SCB0641 can be 0, 1 × 107cfu/L、2×107cfu/L、3×107cfu/L、 4×107cfu/L、5×107cfu/L、6×107cfu/L、7×107cfu/L、8×107cfu/L、9×107cfu/L、 1×108cfu/L、2×108cfu/L、3×108cfu/L、4×108cfu/L、5×108cfu/L、6×108cfu/L、 7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、 4×109cfu/L、5×109cfu/L、6×109cfu/L、7×109cfu/L、8×109cfu/L、9×109cfu/L、 1×1010cfu/L、2×1010cfu/L、3×1010cfu/L、4×1010cfu/L、5×1010cfu/L、6×1010cfu/L、7×1010cfu/L、8×1010cfu/L、8.55×1010cfu/L, etc.;
the Streptococcus thermophilus can be 0, 1 × 106cfu/L、2×106cfu/L、3×106cfu/L、4×106cfu/L、 5×106cfu/L、6×106cfu/L、7×106cfu/L、8×106cfu/L、9×106cfu/L、1×107cfu/L、 2×107cfu/L、3×107cfu/L、4×107cfu/L、5×107cfu/L、6×107cfu/L、7×107cfu/L、 8×107cfu/L、9×107cfu/L、1×108cfu/L、2×108cfu/L、3×108cfu/L、4×108cfu/L、 5×108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、 2×109cfu/L、3×109cfu/L、4×109cfu/L、4.54×109cfu/L, etc.;
the lactobacillus paracasei can be 0, 4 × 108cfu/L、5×108cfu/L、6×108cfu/L、7×108cfu/L、 8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、 5×109cfu/L、6×109cfu/L、7×109cfu/L、7.5×109cfu/L, etc.;
the Lactobacillus plantarum can be 0, 3 × 108cfu/L、4×108cfu/L、5×108cfu/L、6×108cfu/L、 7×108cfu/L、8×108cfu/L、9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、 4×109cfu/L、5×109cfu/L, etc.;
the Lactobacillus casei can be 0, 5.5 × 108cfu/L、6×108cfu/L、7×108cfu/L、8×108cfu/L、 9×108cfu/L、1×109cfu/L、2×109cfu/L、3×109cfu/L、4×109cfu/L、5×109cfu/L、 5.5×109cfu/L, and so on.
The microbial inoculum is obtained by scientific compatibility of the strains, can be used for fermenting and mixing the soybean milk, improves the curd effect and the flavor of the obtained soybean yogurt, can improve the conversion rate of the soybean isoflavone in the soybean yogurt, has high content of free soybean isoflavone aglycone, and has better activity function.
The soybean protein content is 30.8-57.9%, and the soybean protein can be mainly classified into albumin (accounting for about 10%) and globulin (accounting for about 90%). According to immunological analysis, globulin contains 40% of glycinin and 30% of beta-conglycinin, which are main antigen proteins in soybean and are easy to cause adverse reactions such as allergy and the like. However, the two antigen proteins have stronger heat stability, and the heat treatment at the temperature of 100 ℃ has little influence on the antigen activity. The microbial inoculum obtained by the scientific compatibility can also reduce the antigen activity of the soybean yoghourt, thereby improving the nutritional characteristics of the soybean product.
The invention also provides application of the microbial inoculum in preparation of the bean yoghourt.
When the microbial inoculum is used for preparing the soybean yoghourt, the soybean isoflavone glycoside can be converted into soybean isoflavone aglycone so as to play stronger biological activity and health care effect; meanwhile, the bean yoghourt prepared by the microbial inoculum has milk fragrance and bean fragrance, basically eliminates beany flavor, and has better flavor compared with the existing bean yoghourt products on the market.
Preferably, the method for preparing the bean yoghourt comprises the following steps: inoculating the microbial inoculum into the sterilized mixed soybean milk, and fermenting.
Preferably, the inoculation amount of the microbial inoculum in the mixed soybean milk is 3.0 multiplied by 107~9.6×1010cfu/L。
Preferably, the temperature of the fermentation is 25-45 ℃. The fermentation time is 5-24 h.
Preferably, the fermentation is followed by a cold storage after-ripening treatment. More preferably, the refrigerating temperature is 3-5 ℃. The time for cold storage is preferably 6 hours or more than 6 hours.
Preferably, the mixed soybean milk is mainly prepared by mixing a milk matrix and a soybean matrix. More preferably, the mixed soybean milk further comprises a sweetener, and the sweetener is preferably sucrose.
Preferably, the milk base comprises any one or more of fresh milk, powdered milk and condensed milk.
Preferably, the soy base comprises any one or more of fresh soy milk and soy flour.
Preferably, the preparation method of the mixed soybean milk comprises the following steps: mixing 1-8 parts by weight of milk powder, 3-11 parts by weight of bean flour and 1-12 parts by weight of cane sugar with drinking water to obtain 100 parts by weight of materials, and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: mixing 30-50 parts by weight of fresh milk, 40-70 parts by weight of fresh soybean milk and 1-12 parts by weight of sucrose to obtain 100 parts by weight of materials, and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: mixing 1-8 parts by weight of milk powder, 40-60 parts by weight of fresh soybean milk and 1-12 parts by weight of cane sugar with drinking water to obtain 100 parts by weight of material, and uniformly stirring to completely dissolve the material to obtain mixed soybean milk; or the preparation method of the mixed soybean milk comprises the following steps: 30-50 parts by weight of fresh milk, 3-11 parts by weight of bean flour and 1-12 parts by weight of cane sugar are mixed with drinking water to obtain 100 parts by weight of materials, and the materials are uniformly stirred to be completely dissolved to obtain the mixed soybean milk.
The fresh soybean milk is preferably prepared according to a soybean-water weight ratio of 1: 6-1: 10.
The invention mixes the milk matrix and the bean matrix, and the nutritional components of the product are more comprehensive and balanced.
Compared with the prior art, the invention has the beneficial effects that:
the invention separates and identifies the strains with the suitability of the soy milk, obtains the microbial inoculum through reasonable compatibility, ferments the mixed soy milk, can obtain the soy milk with good curd effect and good flavor, can remove part of antigen protein, biologically converts the soy isoflavone, has high content of free soy isoflavone aglycone, and improves the biological activity and the biological utilization rate of the soy isoflavone in the organism.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and other drawings can be obtained by those skilled in the art without creative efforts.
FIG. 1 is a graph showing the comparison of different strains in Experimental example 2 of the present invention with aglycone-producing soybean isoflavones;
FIG. 2 is a graph showing the comparison of the content of the antigen protein after the fermentation of soybean milk by different strains in Experimental example 2 of the present invention;
FIG. 3 is a graph showing the content of soy isoflavones in the mixed soymilk before fermentation in example 3 of the present invention; wherein D represents daidzin, G represents genistin, DE represents daidzein, and GE represents genistein;
FIG. 4 is a graph showing the content of soy isoflavones in soy yogurt obtained by fermentation using a microbial inoculum in example 3 of the present invention;
FIG. 5 is a graph showing the change in the isoflavone content before and after fermentation with the microbial inoculum in example 3 of the present invention.
The bean yogurt adaptive strain provided by the application comprises the following components:
a) lactococcus lactis (Lactococcus lactis), strain number is SCB0469, and the deposit number is: CGMCC 17619;
b) lactobacillus rhamnosus (Lactobacillus rhamnosus), strain number SCB0119, accession number: CGMCC 17618;
c) lactobacillus helveticus (Lactobacillus helveticus), strain number SCB0641, collection number: CGMCC 17620;
are all preserved in China general microbiological culture Collection center, and the preservation addresses are as follows: western road No. 1, north west city of township, beijing, institute of microbiology, china academy of sciences; the strains were detected as viable by the depository at 24/4.2019 and deposited.
Detailed Description
The technical solutions of the present invention will be clearly and completely described below with reference to the accompanying drawings and the detailed description, but those skilled in the art will understand that the following described embodiments are some, not all, of the embodiments of the present invention, and are only used for illustrating the present invention, and should not be construed as limiting the scope of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The lactobacillus rhamnosus SCB0119 is separated from Sichuan pickle;
lactococcus lactis SCB0469 of the present invention was isolated from Russian kefir;
the lactobacillus helveticus SCB0641 of the present invention is isolated from tibetan pleurotus nebrodensis.
The streptococcus thermophilus, the lactobacillus plantarum, the lactobacillus casei and the lactobacillus paracasei adopted in the specific embodiment of the invention can be: streptococcus thermophilus CGMCC1.6472, Lactobacillus plantarum CGMCC1.573, Lactobacillus casei CGMCC1.8727, and Lactobacillus paracasei CGMCC 1.9088.
Example 1
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises four strains of lactococcus lactis SCB0469, Lactobacillus rhamnosus SCB0119, Streptococcus thermophilus and Lactobacillus helveticus SCB0641, wherein the ratio of the lactococcus lactis SCB0469, the Lactobacillus rhamnosus SCB0119, the Streptococcus thermophilus and the Lactobacillus helveticus SCB0641 is 2.0 multiplied by 10 in terms of the number of active bacteria9﹕4.0×109﹕2.5×108﹕8.0×109。
The four strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) taking 2kg of milk powder, 9kg of pure soybean powder and 6kg of cane sugar, adding 100kg of drinking water, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milkCooling to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 8.5 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature, wherein the fermentation temperature is 42 ℃, and the fermentation time is 8 hours; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 2
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactococcus lactis SCB0469, streptococcus thermophilus and lactobacillus helveticus SCB0641, wherein the ratio of the lactococcus lactis SCB0469, the streptococcus thermophilus and the lactobacillus helveticus SCB0641 is 1.2 multiplied by 10 in terms of the number of live bacteria7﹕3.0×106﹕1.8×107。
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) taking 3kg of milk powder, 8kg of pure soybean powder and 6kg of cane sugar, adding 100kg of drinking water, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 3 multiplied by 107cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature for 24h at 25 ℃; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 3
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus rhamnosus SCB0119, lactococcus lactis SCB0469 and streptococcus thermophilus, and the lactobacillus rhamnosus SCB0119 and the lactococcus lactis SCB0469 are counted by the number of the viable bacteriaThe ratio of Streptococcus thermophilus to Streptococcus thermophilus is 6.0X 109﹕3.5×109﹕2.0×108。
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) adding 42kg of drinking water into 7kg of milk powder, 58kg of fresh soybean milk and 2kg of cane sugar, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 9.5 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature for 12h at the fermentation temperature of 30 ℃; and after fermentation is finished, refrigerating and after-ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating and after-ripening time is more than 12 hours, so as to obtain the bean yoghourt.
Example 4
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises five strains of lactococcus lactis SCB0469, Lactobacillus rhamnosus SCB0119, Lactobacillus helveticus SCB0641, Streptococcus thermophilus and Lactobacillus paracasei, wherein the ratio of the lactococcus lactis SCB0469, the Lactobacillus rhamnosus SCB0119, the Lactobacillus helveticus SCB0641, the Streptococcus thermophilus and the Lactobacillus paracasei is 1.5 multiplied by 10 in terms of the number of active bacteria8﹕6.5×107﹕4.3×108﹕2.0×107﹕7.0×109。
The five strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
The method for preparing the bean yoghourt by using the microbial inoculum comprises the following steps:
(1) mixing 32kg of fresh milk, 68kg of fresh soybean milk and 10kg of sucrose, and fully and uniformly stirring to completely dissolve the materials to obtain mixed soybean milk; performing pasteurization on the mixed soybean milk at 90 deg.C for 20 min;
(2) cooling the sterilized mixed soybean milk to 30-40 ℃, and inoculating a microbial inoculum; specifically, the bean yoghourt adaptive microbial inoculum is inoculated into the cooled mixed bean milk, and the total inoculation amount of the microbial inoculum is 7.6 multiplied by 109cfu/L;
(3) Standing the inoculated mixed soybean milk, and fermenting at constant temperature, wherein the fermentation temperature is 35 ℃, and the fermentation time is 13.5 hours; and after fermentation is finished, refrigerating and ripening, wherein the refrigerating temperature is 3-5 ℃, and the refrigerating time is more than 12 hours, so that the bean yoghourt is obtained.
Example 5
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus casei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus casei, the lactococcus lactis SCB0469 to the streptococcus thermophilus is 4.5 multiplied by 10 in terms of the number of live bacteria9﹕1.5×109﹕4.0×107。
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, with the only difference that: the inoculum size using this example was 6X 109cfu/L, and the fermentation time is 18h, so that the bean yoghourt is prepared.
Example 6
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises three strains of lactobacillus paracasei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus paracasei, the lactococcus lactis SCB0469 to the streptococcus thermophilus is 4.5 multiplied by 10 in terms of the number of live bacteria9﹕3.5×108﹕4.0×108。
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 3, except that the inoculum size of this example was 5.3X 109cfu/L, and preparing the bean yoghourt.
Example 7
The embodiment provides a bean yogurt adaptive microbial inoculum which comprises three strains of lactobacillus plantarum, lactococcus lactis SCB0469 and streptococcus thermophilusThe ratio of Lactobacillus plantarum to lactococcus lactis SCB0469 to Streptococcus thermophilus was 4.5X 10 in terms of viable count8﹕5.5×109﹕4.0×108。
The three strains are mixed in proportion to obtain the soy yogurt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 3, except that the inoculum size of this example was 5.6X 109cfu/L, fermenting for 18h, and preparing the bean yoghourt.
Example 8
The embodiment provides a bean yogurt adaptive microbial inoculum, which comprises four strains of lactobacillus helveticus SCB0641, lactobacillus paracasei, lactococcus lactis SCB0469 and streptococcus thermophilus, wherein the ratio of the lactobacillus helveticus SCB0641, the lactobacillus paracasei, the lactococcus lactis SCB0469 and the streptococcus thermophilus is 5.0 multiplied by 10 in terms of the number of living bacteria9﹕4.5×108﹕8.5×108﹕1.0×109。
The four strains are mixed in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, except that the inoculum size of this example was 7.3X 109cfu/L, fermenting for 18h, and preparing the bean yoghourt.
Example 9
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises seven strains of lactobacillus rhamnosus SCB0119, lactobacillus helveticus SCB0641, lactobacillus paracasei, lactobacillus lactis SCB0469, lactobacillus plantarum, lactobacillus casei and streptococcus thermophilus, wherein the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactobacillus paracasei, the lactobacillus lactis SCB0469, the lactobacillus plantarum, the lactobacillus casei and the streptococcus thermophilus is 3.5 multiplied by 10 in terms of the number of the viable bacteria8﹕4.0×109﹕4.5×108﹕1.5×108﹕3.0×108﹕5.5×109﹕1.0×108。
Mixing the seven strains in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to example 2Method for preparing a soy yogurt, the only difference being that the inoculum size used in this example was 1.13X 1010cfu/L, fermenting for 16h, and preparing the bean yoghourt.
Example 10
The embodiment provides a soybean yoghourt adaptive microbial inoculum, which comprises seven strains of lactobacillus rhamnosus SCB0119, lactobacillus helveticus SCB0641, lactobacillus paracasei, lactobacillus lactis SCB0469, lactobacillus plantarum, lactobacillus casei and streptococcus thermophilus, wherein the ratio of the lactobacillus rhamnosus SCB0119, the lactobacillus helveticus SCB0641, the lactobacillus paracasei SCB0469, the lactobacillus plantarum, the lactobacillus casei and the streptococcus thermophilus is 2.5 multiplied by 10 in terms of the number of live bacteria9﹕4.0×108﹕5.5×109﹕2.5×109﹕5.0×109﹕5.5×108﹕3.0×109。
Mixing the seven strains in proportion to obtain the bean yoghourt adaptive microbial inoculum.
This example refers to the method of making soy yogurt of example 2, except that the total inoculum size using this example is 1.9X 1010cfu/L, fermenting for 16h, and preparing the bean yoghourt.
Comparative example 1
Comparative example 1 the preparation process of example 3 was referenced, except that the inoculated fermentation broth was CGMCC1.16075 and Streptococcus thermophilus CGMCC1.6472 at a ratio of 5.5X 109﹕4.0×109Inoculation amount of 9.5X 109cfu/L。
Experimental example 1
The experimental method comprises the following steps:
the lactococcus lactis (all isolated from kefir) stored in the laboratory was removed from the ultra-low temperature refrigerator and inoculated into 8mL of MRS liquid medium by using a sterile pipette in an inoculum size of 1% (v/v) and cultured at 37 ℃ for 12 hours, and passaging was performed once in the same manner.
Then, the activated liquid strain is inoculated into the mixed soymilk (5% pure soybean powder, 5% whole milk powder, 8% white granulated sugar, pasteurization at 90 ℃ for 20min, cooling to 40 ℃) according to the inoculation amount of 1% (v/v), and placed at 25 ℃ for culturing for 24 h.
And observing and recording the fermentation condition, measuring the pH value of the fermented soybean yoghourt by using a pH meter, observing the curd condition by naked eyes, judging the viscosity by drawing the toothpick, and evaluating the smell of the soybean yoghourt in a sensory manner.
The experimental results are as follows:
experimental example 1 the fermented effect of the soybean yogurt with lactococcus lactis was screened, and the results are shown in Table 1 below.
TABLE 1 screening of fermented Soybean yogurt Strain lactococcus lactis
Note: "+" indicates curd, "-" indicates no curd; a sticky condition "+" indicates sticky and "-" indicates not sticky; the savoury soymilk taste is a mixed taste of the flavour of soymilk and the flavour of sour milk in yoghurt.
As can be seen from Table 1, the screened lactococcus lactis fermented soy yogurt at 25 ℃ for 24h, the curd was poor, and only SCB0427 and SCB0469 fermented soy yogurt curds. The strain with stronger acid production is SCB0427, and the pH value is 5.25. The fermented soybean yoghourt has poor viscosity, most of the fermented soybean yoghourt has soybean milk flavor, and the part of the fermented soybean yoghourt has sour and fragrant soybean milk flavor, wherein the fermented soybean milk has the sour and fragrant soybean milk flavor of SCB0427, SCB0431, SCB0433, SCB0449, SCB0469 and SCB 0477. By combining the indexes, the selected SCB0469 fermented soybean yoghourt has better curd effect, the pH values are respectively 5.25 and 5.46, the soybean yoghourt has proper odor, and the soybean yoghourt is suitable for being fermented.
Experimental example 2
Experimental example 2 conditions of aglycone-producing soybean isoflavones and contents of antigen proteins after fermented soybean milk were tested according to different strains, as shown in FIGS. 1 and 2.
The test method comprises the following steps:
soaking soybeans: adding 0.5% NaHCO to the washed soybeans3Soaking the solution at room temperature for 10 hr at a ratio of 1: 3 to make the soybean fully swell.
Blanching: washing the soaked soybeans with distilled water, and blanching at 85-90 deg.C for 10 min.
Grinding: grinding the scalded soybean with beating machine at ratio of 1: 6 for 2min, filtering with 4 layers of gauze, and removing bean dregs.
Sterilization and inoculation fermentation: heating soybean milk to 100 deg.C, boiling for 6min, keeping the temperature at 90 deg.C for 15-20min, cooling to 30 deg.C, inoculating various lactobacillus strains (culture solution after three generations of MRS liquid culture medium activation) according to 2%, shaking, mixing, standing at 25 deg.C, fermenting for 24h, and measuring the contents of two antigen proteins with the fermentation liquid as follows.
The method for measuring the soybean antigenic protein comprises the following steps:
extraction of soybean antigen protein sample: taking 1.0mL of a sample to be detected, soaking the sample in 20.0mL of 0.03mol/L Tris-HCl (pH 8.0 and including 0.01mol/L beta-mercaptoethanol) buffer solution, soaking the sample on a shaking table at the temperature of 28 ℃ for 1h at the speed of 150r/min, then centrifuging the sample at the speed of 4000r/min for 20min, and taking a supernatant for later use.
And (3) detecting the immunological activity: the assay of glycinin was performed according to the method in the purchased antigenic protein ELISA kit (96 wells). Soybean antigenic protein ELISA kit (purchased from Yu duo Biotech, Inc. of Shanghai).
As can be seen from FIG. 1, SCB0641 can significantly increase the content of Daidzein (DE) and Genistin (GE) in fermented soy isoflavone and increase the content of free soy isoflavone aglycone, thereby increasing the bioactivity and bioavailability of soy isoflavone in vivo, compared with other strains.
As can be seen from FIG. 2, SCB0119 can obviously reduce the antigenic contents of two antigenic proteins, namely beta-conglycinin (SPAg) and glycinin (SPA), and the strain can also improve the content of genistin.
Experimental example 3
In order to illustrate the fermentation effect of the microbial inoculum of the invention on the mixed soybean milk, taking example 3 as an example, the content of the soybean isoflavone in the mixed soybean milk before fermentation and the soybean yogurt obtained after fermentation is measured, and the test results are shown in fig. 3-5, fig. 3 is a graph of the content of the soybean isoflavone in the mixed soybean milk before fermentation, fig. 4 is a graph of the content of the soybean isoflavone in the soybean yogurt obtained after fermentation, and fig. 5 is a graph of the change of the content of the soybean isoflavone before and after fermentation. It can be known from the figure that before fermentation, the content of daidzin (D) and genistin (G) is higher, after fermentation, the content of daidzin and genistin is relatively reduced, and meanwhile, the content of Daidzein (DE) and Genistein (GE) is obviously improved, which shows that the microbial inoculum of the invention ferments the mixed soybean milk, can biologically convert the soybean isoflavone, improves the content of free soybean isoflavone aglycone, and further improves the biological activity and bioavailability of the soybean isoflavone in the body.
Experimental example 4
In order to comparatively illustrate the fermentation effect of different microbial agents of the present invention on mixed soybean milk, the content of soybean isoflavone and the degradation of antigen protein in the soybean yogurt obtained by fermentation in examples 1 to 10 and comparative example 1 were tested, and the test results are shown in table 2.
TABLE 2 content of soy isoflavones in different soy yoghurts (unit: μ g/mL soy yoghurt)
Numbering | Daidzin | Genistin | Daidzein | Genistein | D value |
Example 1 | 78.3±2.7 | 75.9±1.2 | - | 0.43±0.04 | 1.53 |
Example 2 | 81.1±4.2 | 78±0.3 | - | 0.11±0.02 | 1.32 |
Example 3 | 52.2±2.3 | 45.9±2.2 | 12.2±1.2 | 15.8±2.8 | 14.52 |
Example 4 | 65.3±2.3 | 69.6±5.4 | 9.3±0.8 | 6.9±0.2 | 1.22 |
Example 5 | 82.2±3.4 | 75.3±4.8 | - | 0.6±0.04 | 0.13 |
Example 6 | 76.3±4.5 | 76.8±0.4 | 0.4±0.04 | - | -0.05 |
Example 7 | 77.3±0.9 | 75.5±6.2 | 3.0±0.43 | 0.4±0.02 | 0.22 |
Example 8 | 57.2±2.9 | 51.3±0.8 | 8.3±0.12 | 10.2±0.44 | -0.43 |
Example 9 | 60.4±2.2 | 49.3±4.3 | 10.2±0.5 | 14.3±3.2 | 5.66 |
Example 10 | 43.4±3.4 | 46.2±4.5 | 16.0±3.2 | 20.2±4.8 | 12.26 |
Comparative example 1 | 82.3±2.1 | 76.3±5.4 | - | - | 0.11 |
Note: calculation of D value: (content of antigen protein in soymilk before fermentation-content of antigen protein in soymilk after fermentation)/content of antigen protein in soymilk before fermentation X100
As can be seen from Table 2, the soy yogurt adaptive strain of the present invention can biologically convert soy isoflavones, significantly increase the content of free soy isoflavone aglycones, and increase the biological activity and bioavailability of soy isoflavones in the body.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
SEQUENCE LISTING
<110> southern China university of agriculture
<120> soy yogurt adaptive strain, microbial inoculum and application thereof
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 1380
<212> DNA
<213> Lactobacillus rhamnosus
<400> 1
gcttgcatct tgatttaatt ttgaacgagt ggcggacggg tgagtaacac gtgggtaacc 60
tgcccttaag tgggggataa catttggaaa cagatgctaa taccgcataa atccaagaac 120
cgcatggttc ttggctgaaa gatggcgtaa gctatcgctt ttggatggac ccgcggcgta 180
ttagctagtt ggtgaggtaa cggctcacca aggcaatgat acgtagccga actgagaggt 240
tgatcggcca cattgggact gagacacggc ccaaactcct acgggaggca gcagtaggga 300
atcttccaca atggacgcaa gtctgatgga gcaacgccgc gtgagtgaag aaggctttcg 360
ggtcgtaaaa ctctgttgtt ggagaagaat ggtcggcaga gtaactgttg tcggcgtgac 420
ggtatccaac cagaaagcca cggctaacta cgtgccagca gccgcggtaa tacgtaggtg 480
gcaagcgtta tccggattta ttgggcgtaa agcgagcgca ggcggttttt taagtctgat 540
gtgaaagccc tcggcttaac cgaggaagtg catcggaaac tgggaaactt gagtgcagaa 600
gaggacagtg gaactccatg tgtagcggtg aaatgcgtag atatatggaa gaacaccagt 660
ggcgaaggcg gctgtctggt ctgtaactga cgctgaggct cgaaagcatg ggtagcgaac 720
aggattagat accctggtag tccatgccgt aaacgatgaa tgctaggtgt tggagggttt 780
ccgcccttca gtgccgcagc taacgcatta agcattccgc ctggggagta cgaccgcaag 840
gttgaaactc aaaggaattg acgggggccc gcacaagcgg tggagcatgt ggtttaattc 900
gaagcaacgc gaagaacctt accaggtctt gacatctttt gatcacctga gagatcaggt 960
ttccccttcg ggggcaaaat gacaggtggt gcatggttgt cgtcagctcg tgtcgtgaga 1020
tgttgggtta agtcccgcaa cgagcgcaac ccttatgact agttgccagc atttagttgg 1080
gcactctagt aagactgccg gtgacaaacc ggaggaaggt ggggatgacg tcaaatcatc 1140
atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaacg agttgcgaga 1200
ccgcgaggtc aagctaatct cttaaagcca ttctcagttc ggactgtagg ctgcaactcg 1260
cctacacgaa gtcggaatcg ctagtaatcg cggatcagca cgccgcggtg aatacgttcc 1320
cgggccttgt acacaccgcc cgtcacacca tgagagtttg taacacccga agccggtggc 1380
<210> 2
<211> 1419
<212> DNA
<213> Lactococcus lactis
<400> 2
gagcgccctc cttgcggtta ggcaacctac ttcgggtact cccaactccc gtggtgtgac 60
gggcggtgtg tacaaggccc gggaacgtat tcaccgcggc gtgctgatcc gcgattacta 120
gcgattccga cttcatgtag gcgagttgca gcctacaatc cgaactgaga atggttttaa 180
gagattagct aaacatcact gtctcgcgac tcgttgtacc atccattgta gcacgtgtgt 240
agcccaggtc ataaggggca tgatgatttg acgtcatccc caccttcctc cggtttatca 300
ccggcagtct cgttagagtg cccaacttaa tgatggcaac taacaatagg ggttgcgctc 360
gttgcgggac ttaacccaac atctcacgac acgagctgac gacaaccatg caccacctgt 420
atcccgtgtc ccgaaggaac ttcctatctc taggaatagc acgagtatgt caagacctgg 480
taaggttctt cgcgttgctt cgaattaaac cacatgctcc accgcttgtg cgggcccccg 540
tcaattcctt tgagtttcaa ccttgcggtc gtactcccca ggcggagtgc ttattgcgtt 600
agctgcgata cagagaactt atagctccct acatctagca ctcatcgttt acggcgtgga 660
ctaccagggt atctaatcct gtttgctccc cacgctttcg agcctcagtg tcagttacag 720
gccagagagc cgctttcgcc accggtgttc ctccatatat ctacgcattt caccgctaca 780
catggaattc cactctcctc tcctgcactc aagtctacca gtttccaatg catacaatgg 840
ttgagccact gccttttaca ccagacttaa taaaccacct gcgctcgctt tacgcccaat 900
aaatccggac aacgctcggg acctacgtat taccgcggct gctggcacgt agttagccgt 960
ccctttctgg gtagttaccg tcacttgatg agctttccac tctcaccaac gttcttctct 1020
accaacagag ttttacgatc cgaaaacctt cttcactcac gcggcgttgc tcggtcagac 1080
tttcgtccat tgccgaagat tccctactgc tgcctcccgt aggagtttgg gccgtgtctc 1140
agtcccaatg tggccgatca ccctctcagg tcggctatgt atcatcgcct tggtgagcct 1200
ttacctcacc aactagctaa tacaacgcgg gatcatcttt gagtgatgca attgcatctt 1260
tcaaacttaa aacttgtgtt taaagttttt atgcggtatt agcattcgtt tccaaatgtt 1320
gtcccccgct caaaggcaga ttccccacgc gttactcacc cgttcgctgc tcatccagtt 1380
ggtacaagta ccaaccttca gcgctcaact tgcatgtat 1419
<210> 3
<211> 1409
<212> DNA
<213> Lactobacillus helveticus
<400> 3
ggccaccggc tttgggcatt gcagacttcc atggtgtgac gggcggtgtg tacaaggccc 60
gggaacgtat tcaccgcggc gttctgatcc gcgattacta gcgattccag cttcgtgcag 120
tcgagttgca gactgcagtc cgaactgaga acagctttca gagattcgct tgccttcgca 180
ggctcgcttc tcgttgtact gcccattgta gcacgtgtgt agcccaggtc ataaggggca 240
tgatgacttg acgtcatccc caccttcctc cggtttgtca ccggcagtct cattagagtg 300
cccaacttaa tgctggcaac taataataag ggttgcgctc gttgcgggac ttaacccaac 360
atctcacgac acgagctgac gacagccatg caccacctgt cttagcgtcc ccgaagggaa 420
ctcctaatct cttaggatgg cactagatgt caagacctgg taaggttctt cgcgttgctt 480
cgaattaaac cacatgctcc accgcttgtg cgggcccccg tcaattcctt tgagtttcaa 540
ccttgcggtc gtactcccca ggcggagtgc ttaatgcgtt agctgcagca ctgagaggcg 600
gaaacctccc aacacttagc actcatcgtt tacggcatgg actaccaggg tatctaatcc 660
tgttcgctac ccatgctttc gagcctcagc gtcagttgca gaccagagag ccgccttcgc 720
cactggtgtt cttccatata tctacgcatt ccaccgctac acatggagtt ccactctcct 780
cttctgcact caagaaaaac agtttccgat gcaattcctc ggttaagccg agggctttca 840
catcagactt attcttccgc ctgcgctcgc tttacgccca ataaatccgg acaacgcttg 900
ccacctacgt attaccgcgg ctgctggcac gtagttagcc gtgactttct ggttgattac 960
cgtcaaataa aggccagtta ctacctctat ccttcttcac caacaacaga gctttacgat 1020
ccgaaaacct tcttcactca cgcggcgttg ctccatcaga cttgcgtcca ttgtggaaga 1080
ttccctactg ctgcctcccg taggagtttg ggccgtgtct cagtcccaat gtggccgttc 1140
agtctctcaa ctcggctatg catcattgcc ttggtaagcc gttaccttac caactagcta 1200
atgcaccgcg gggccatccc atagcgacag cttacgccgc cttttataag ctgatcatgc 1260
gatctgcttt attatccggt attagcacct gtttccaagt ggtatcctag actatggggc 1320
aggttcccca cgtgttactc acccatccgc cgctcgcgtc cccagcgtca ttaccgaagt 1380
aaatctgctg gttctgctcg ctcgacttg 1409
Claims (42)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910534345.8A CN110129243B (en) | 2019-06-20 | 2019-06-20 | Soy yogurt suitable strains, inoculants and their applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910534345.8A CN110129243B (en) | 2019-06-20 | 2019-06-20 | Soy yogurt suitable strains, inoculants and their applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110129243A CN110129243A (en) | 2019-08-16 |
CN110129243B true CN110129243B (en) | 2021-02-23 |
Family
ID=67578818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910534345.8A Active CN110129243B (en) | 2019-06-20 | 2019-06-20 | Soy yogurt suitable strains, inoculants and their applications |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110129243B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202200007118A1 (en) * | 2022-04-11 | 2023-10-11 | Univ Degli Studi Di Firenze | LACTIC BACTERIA FOR THE PREPARATION OF DRINKS OR VEGETABLE FOODS ENRICHED IN G-AMINOBUTYRIC ACID |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111197018B (en) * | 2020-01-13 | 2020-11-06 | 河北农业大学 | Lactobacillus acidi, method for fermenting soybean milk with the same, and prepared fermented soybean milk and application |
CN111616227A (en) * | 2020-03-30 | 2020-09-04 | 华南农业大学 | A kind of physalis tofu rich in aglycone isoflavones and preparation method thereof |
CN111602721A (en) * | 2020-05-08 | 2020-09-01 | 华南农业大学 | A kind of method for promoting fermentation of plant yogurt and application thereof |
CN115873749B (en) * | 2022-08-22 | 2024-05-03 | 黑龙江飞鹤乳业有限公司 | Microbial inoculum, fermented plant-based yoghurt and preparation method thereof |
CN115386523B (en) * | 2022-09-30 | 2024-01-30 | 北京诺安百汇医药科技有限公司 | Lactococcus lactis and application thereof in resisting helicobacter pylori infection |
CN116138400A (en) * | 2023-01-04 | 2023-05-23 | 广东鸿景农业科技有限公司 | Soybean yoghurt fermented by new soybean varieties and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103355406B (en) * | 2013-06-20 | 2015-08-19 | 宁波大学 | A kind of production method being rich in active polysaccharide Fermented Soybean Milk |
-
2019
- 2019-06-20 CN CN201910534345.8A patent/CN110129243B/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202200007118A1 (en) * | 2022-04-11 | 2023-10-11 | Univ Degli Studi Di Firenze | LACTIC BACTERIA FOR THE PREPARATION OF DRINKS OR VEGETABLE FOODS ENRICHED IN G-AMINOBUTYRIC ACID |
Also Published As
Publication number | Publication date |
---|---|
CN110129243A (en) | 2019-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110129243B (en) | Soy yogurt suitable strains, inoculants and their applications | |
US4702923A (en) | Lyophilized kefir yoghurt health food | |
CN101861895B (en) | Method for preparing novel fermented soybean milk products | |
CN102422882B (en) | Soybean-honey acidophilus milk and preparation method thereof | |
CN110106119B (en) | Lactobacillus rhamnosus M9 separated from breast milk and application thereof | |
CZ291067B6 (en) | Lactobacillus helveticus bacterium producing lactic acid, fermented milk product and process for preparing thereof | |
CN109517763B (en) | Lactobacillus helveticus H11 and application thereof | |
CN104305465B (en) | The preparation method of lactic acid bacteria fermentation type blue berry fruit juice | |
CN102986872A (en) | Fermented egg yoghurt containing chickpeas and method for preparing egg yoghurt | |
CN111955548B (en) | Pure probiotic flavored fermented milk and preparation method thereof | |
CN115261264A (en) | Lactobacillus paracasei PC804 and application thereof | |
CN112852684B (en) | Lactobacillus plantarum strain Y388 and application thereof | |
CN109337833B (en) | Biological preparation of mutagenic leuconostoc mesenteroides and application thereof | |
CN102697010B (en) | A kind of fermented vegetables and preparation method thereof | |
KR100882278B1 (en) | Soybean yoghurt fermented with kimchi lactic acid bacteria and its manufacturing method | |
CN101223911A (en) | Mushroom yoghurt and its production process | |
JP2010505390A (en) | Use of gum arabic to improve the growth and survival of bifidobacteria | |
CN110250270B (en) | A kind of method that utilizes Lactobacillus plantarum to improve fermented milk folic acid content | |
CN113693205A (en) | Healthy flavored soybean milk formula and production process thereof | |
CN109266572B (en) | Lactobacillus casei mutant strain for producing glutamine transaminase and application thereof | |
CN107099482A (en) | A kind of Pediococcus pentosaceus and its application | |
CN109504636A (en) | A kind of lactobacillus plantarum P12 and application thereof | |
CN109430402A (en) | A kind of preparation method of fermented type oat dairy products | |
KR101022797B1 (en) | Method for preparing soymilk yogurt using soybean water and mixed lactic acid bacteria and soymilk yogurt prepared thereby | |
KR20120003573A (en) | Enterococcus faecalis having an intestinal flora normalizing effect, fermented product comprising the same, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |